Drug Type Enzyme |
Synonyms PtsaN C, PtsaNC |
Target |
Mechanism ROS1 inhibitors(Proto-oncogene tyrosine-protein kinase ROS inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myocardial Reperfusion Injury | Preclinical | CN | 23 Feb 2024 |